Primary |
Drug Use For Unknown Indication |
23.3% |
Rhinitis |
16.7% |
Rhinitis Allergic |
11.1% |
Sinusitis |
10.0% |
Seasonal Allergy |
7.8% |
Asthma |
4.4% |
Cardiac Disorder |
4.4% |
Nasal Congestion |
3.3% |
Product Used For Unknown Indication |
3.3% |
Acute Sinusitis |
2.2% |
Chronic Sinusitis |
2.2% |
Cough |
2.2% |
Adenoidal Hypertrophy |
1.1% |
Contraception |
1.1% |
Depression |
1.1% |
Fungal Infection |
1.1% |
House Dust Allergy |
1.1% |
Hypersensitivity |
1.1% |
Infection |
1.1% |
Lower Respiratory Tract Infection |
1.1% |
|
Tremor |
9.1% |
Anosmia |
7.3% |
Epistaxis |
7.3% |
Pharmaceutical Product Complaint |
7.3% |
Drug Exposure During Pregnancy |
5.5% |
Nasal Mucosa Atrophy |
5.5% |
Nasal Oedema |
5.5% |
Rash |
5.5% |
Urticaria |
5.5% |
Visual Acuity Reduced |
5.5% |
Colitis Ulcerative |
3.6% |
Deafness |
3.6% |
Diabetes Mellitus Inadequate Control |
3.6% |
Dyspnoea |
3.6% |
Exposure During Breast Feeding |
3.6% |
Foetal Exposure During Pregnancy |
3.6% |
Glaucoma |
3.6% |
Nasal Septum Perforation |
3.6% |
Scratch |
3.6% |
Sensation Of Foreign Body |
3.6% |
|
Secondary |
Sinus Disorder |
47.8% |
Upper Respiratory Tract Infection |
13.3% |
Asthma |
7.8% |
Drug Use For Unknown Indication |
6.7% |
Rhinitis |
3.3% |
Bronchitis |
2.2% |
Osteoporosis |
2.2% |
Osteoporosis Postmenopausal |
2.2% |
Rheumatoid Arthritis |
2.2% |
Breast Cancer |
1.1% |
Bronchial Obstruction |
1.1% |
Bronchiectasis |
1.1% |
Chronic Obstructive Pulmonary Disease |
1.1% |
Contraception |
1.1% |
Dry Eye |
1.1% |
Fungal Infection |
1.1% |
Gastric Disorder |
1.1% |
Hypertension |
1.1% |
Injection Site Reaction |
1.1% |
Insomnia |
1.1% |
|
Adrenal Suppression |
12.5% |
Intra-uterine Death |
12.5% |
Lung Infiltration |
12.5% |
Vision Blurred |
12.5% |
Allergic Granulomatous Angiitis |
6.3% |
Dyspnoea |
6.3% |
Foetal Exposure During Pregnancy |
6.3% |
Osteonecrosis |
6.3% |
Renal Impairment |
6.3% |
Sinus Disorder |
6.3% |
Unintended Pregnancy |
6.3% |
Vomiting |
6.3% |
|
Concomitant |
Product Used For Unknown Indication |
32.0% |
Drug Use For Unknown Indication |
15.4% |
Asthma |
8.5% |
Rheumatoid Arthritis |
8.0% |
Hypertension |
5.5% |
Anaesthesia |
4.2% |
Pain |
4.2% |
Muscle Relaxant Therapy |
2.2% |
Angina Pectoris |
2.0% |
Duodenal Ulcer |
2.0% |
Rhinitis Allergic |
2.0% |
Bronchitis |
1.9% |
Muscle Spasms |
1.7% |
Sinus Disorder |
1.7% |
Cough |
1.6% |
Migraine |
1.6% |
Blood Pressure |
1.4% |
Sinusitis |
1.4% |
Epilepsy |
1.3% |
Prophylaxis |
1.3% |
|
Vomiting |
14.0% |
Renal Failure |
10.5% |
Pain |
9.3% |
Visual Disturbance |
8.1% |
Wheezing |
7.0% |
Hodgkin's Disease |
5.8% |
Mobility Decreased |
5.8% |
Vertigo |
4.7% |
Asthma |
3.5% |
Melaena |
3.5% |
Mental Disorder |
3.5% |
Renal Tubular Necrosis |
3.5% |
Somnolence |
3.5% |
Tinnitus |
3.5% |
Abdominal Pain Upper |
2.3% |
Dermatitis Exfoliative |
2.3% |
Gastric Ulcer Perforation |
2.3% |
Musculoskeletal Chest Pain |
2.3% |
Pruritus |
2.3% |
Rash Pruritic |
2.3% |
|